Abstract:The glutamate transporter GLT‐1 is predominantly expressed in astrocytes. In neurons, GLT‐1 is expressed mainly in axon terminals. Conditional knockout of the gene expressing GLT‐1 in neurons prevents recovery of hippocampal synaptic function by increased vulnerability to excitotoxic injury. Hippocampal slices from these mutant mice have multiple neuronal and astrocytic abnormalities of glucose metabolism, including reduced glucose oxidation, decreased phosphorylation of pyruvate dehydrogenase, and delayed replenishment of glycogen stores. Targeting mitochondrial superoxide production prevents excitotoxic injury and restores synaptic function. Excitotoxicity thus appears to be finely controlled by mitochondrial superoxide homeostasis tightly linked to the metabolic functions of neuronal GLT‐1. We have previously reported a failure of recovery of synaptic function in the CA1 region of acute hippocampal slices from mice with a conditional neuronal knockout (KO) of GLT‐1 (EAAT2, Slc1A2) driven by synapsin‐Cre (synGLT‐1 KO). The failure of recovery of synaptic function is due to excitotoxic injury. We hypothesized that changes in mitochondrial metabolism contribute to the heightened vulnerability to excitotoxicity in the synGLT‐1 KO mice. We found impaired flux of carbon from 13C‐glucose into the tricarboxylic acid cycle in synGLT‐1 KO cortical and hippocampal slices compared with wild‐type (WT) slices. In addition, we found downregulation of the neuronal glucose transporter GLUT3 in both genotypes. Flux of carbon from [1,2‐13C]acetate, thought to be astrocyte‐specific, was increased in the synGLT‐KO hippocampal slices but not cortical slices. Glycogen stores, predominantly localized to astrocytes, are rapidly depleted in slices after cutting, and are replenished during ex vivo incubation. In the synGLT‐1 KO, replenishment of glycogen stores during ex vivo incubation was compromised. These results suggest both neuronal and astrocytic metabolic perturbations in the synGLT‐1 KO slices. Supplementing incubation medium during recovery with 20 mM D‐glucose normalized glycogen replenishment but had no effect on recovery of synaptic function. In contrast, 20 mM non‐metabolizable L‐glucose substantially improved recovery of synaptic function, suggesting that D‐glucose metabolism contributes to the excitotoxic injury in the synGLT‐1 KO slices. L‐lactate substitution for D‐glucose did not promote recovery of synaptic function, implicating mitochondrial metabolism. Consistent with this hypothesis, phosphorylation of pyruvate dehydrogenase, which decreases enzyme activity, was increased in WT slices during the recovery period, but not in synGLT‐1 KO slices. Since metabolism of glucose by the mitochondrial electron transport chain is associated with superoxide production, we tested the effect of drugs that scavenge and prevent superoxide production. The superoxide dismutase/catalase mimic EUK‐134 conferred complete protection and full recovery of synaptic function. A site‐specific inhibitor of complex III superoxide production, S3QEL‐2, was also protective, but inhibitors of NADPH oxidase were not. In summary, we find that the failure of recovery of synaptic function in hippocampal slices from the synGLT‐1 KO mouse, previously shown to be due to excitotoxic injury, is caused by production of superoxide by mitochondrial metabolism.

Metabolic reprogramming in astrocytes results in neuronal dysfunction in intellectual disability

Characteristic Metabolic Alterations Identified in Primary Neurons under High Glucose Exposure

Metabonomic profiles delineate potential role of glutamate-glutamine cycle in db/db mice with diabetes-associated cognitive decline

Astrocytes Gate Long-Term Potentiation in Hippocampal Interneurons

Single-nucleus transcriptional profiling uncovers the reprogrammed metabolism of astrocytes in Alzheimer's disease.

Restoring hippocampal glucose metabolism rescues cognition across Alzheimer's disease pathologies

Metabolic Rewiring and Altered Glial Differentiation in an iPSC-Derived Astrocyte Model Derived from a Nonketotic Hyperglycinemia Patient

Reprogramming astrocytic NDRG2/NF-κB/C3 signaling restores the diabetes-associated cognitive dysfunction

Reprogramming astrocytic NDRG2/NF-κB/C3 signaling restores the diabetes-associated cognitive dysfunctionResearch in context

Blue native/SDS-PAGE combined with iTRAQ analysis reveals advanced glycation end-product-induced changes of synaptosome proteins in C57 BL/6 mice

Deficient brain GABA metabolism leads to widespread impairments of astrocyte and oligodendrocyte function

KAT6A deficiency impairs cognitive functions through suppressing RSPO2/Wnt signaling in hippocampal CA3

Neuron-specific mitochondrial oxidative stress results in epilepsy, glucose dysregulation and a striking astrocyte response

SYNGAP1 deficiency disrupts synaptic neoteny in xenotransplanted human cortical neurons in vivo

Metabolic modulation of synaptic failure and thalamocortical hypersynchronization with preserved consciousness in Glut1 deficiency

Misprogramming of glucose metabolism impairs recovery of hippocampal slices from neuronal GLT‐1 knockout mice and contributes to excitotoxic injury through mitochondrial superoxide production

Epigenetic Modulation to perturb the Intellectual Disability (ID) that ameliorates synaptic and behavioural deficits

Impaired calcium signaling in astrocytes modulates autism spectrum disorder-like behaviors in mice